TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
HK Stock MarketDetailed Quotes
00570 TRAD CHI MED
- 2.270
- -0.030-1.30%
Not Open Dec 20 16:08 CST
11.43BMarket Cap11.35P/E (TTM)
2.310High2.270Low26.18MVolume2.310Open2.300Pre Close59.72MTurnover0.52%Turnover Ratio8.05P/E (Static)5.04BShares4.46052wk High0.49P/B11.43BFloat Cap2.12052wk Low--Dividend TTM5.04BShs Float7.108Historical High--Dividend LFY1.74%Amplitude-0.532Historical Low2.281Avg Price2000Lot Size--Div YieldTTM--Div Yield LFY
TRAD CHI MED Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 45.76%1.22B | ---- | -66.67%840.11M | ---- | 13.01%2.52B | ---- | 3.50%2.23B | ---- | 16.05%2.15B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 2.99%-65.26M | ---- | -7.50%-67.27M | ---- | -31.46%-62.58M | ---- | 7.12%-47.6M | ---- | -18.51%-51.25M |
| Attributable subsidiary (profit) loss | ---- | 6.32%3.7M | ---- | -67.63%3.48M | ---- | -32.29%10.75M | ---- | 214.27%15.87M | ---- | -28.13%5.05M |
| Impairment and provisions: | ---- | -81.76%39.79M | ---- | 124.96%218.1M | ---- | 532.30%96.95M | ---- | -60.54%15.33M | ---- | 166.08%38.86M |
| -Impairment of property, plant and equipment (reversal) | ---- | -84.62%20.77M | ---- | 1,016.32%135.08M | ---- | --12.1M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | -60.84%9.65M | ---- | -34.81%24.63M | ---- | 146.42%37.78M | ---- | -60.54%15.33M | ---- | 166.08%38.86M |
| -Impairment of trade receivables (reversal) | ---- | -20.28%8.78M | ---- | -21.78%11.01M | ---- | --14.08M | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | 20.46%35.87M | ---- | --29.78M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -94.90%587K | ---- | 258.77%11.51M | ---- | --3.21M | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -13,725.00%-553K | ---- | 98.96%-4K |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -13,725.00%-553K | ---- | 98.96%-4K |
| Asset sale loss (gain): | ---- | -610.41%-33.72M | ---- | 80.65%-4.75M | ---- | -28,757.65%-24.53M | ---- | 99.65%-85K | ---- | -797.77%-24.57M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 102.10%128K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -454.92%-26.34M | ---- | 80.68%-4.75M | ---- | -7,626.10%-24.57M | ---- | -104.31%-318K | ---- | 120.28%7.39M |
| -Loss (gain) from selling other assets | ---- | ---7.38M | ---- | ---- | ---- | -82.83%40K | ---- | 100.73%233K | ---- | ---32.09M |
| Depreciation and amortization: | ---- | 6.83%1.09B | ---- | 25.61%1.02B | ---- | 27.33%813.32M | ---- | 14.13%638.74M | ---- | 11.79%559.68M |
| -Depreciation | ---- | 3.08%1.13B | ---- | 29.40%1.1B | ---- | 24.20%849.6M | ---- | 15.78%684.08M | ---- | 15.93%590.83M |
| -Other depreciation and amortization | ---- | 46.20%-41.84M | ---- | -114.40%-77.78M | ---- | 20.00%-36.28M | ---- | -45.56%-45.34M | ---- | -246.16%-31.15M |
| Financial expense | ---- | -9.81%199.05M | ---- | -0.60%220.7M | ---- | -9.25%222.03M | ---- | -18.73%244.67M | ---- | 2.99%301.05M |
| Exchange Loss (gain) | ---- | 228.21%384K | ---- | 115.29%117K | ---- | 42.78%-765K | ---- | -110.22%-1.34M | ---- | 234.53%13.08M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 39.64%69.78M | ---- | 155.13%49.97M |
| Operating profit before the change of operating capital | ---- | 10.20%2.46B | ---- | -37.57%2.23B | ---- | 12.97%3.58B | ---- | 3.89%3.16B | ---- | 20.67%3.05B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 106.94%70.94M | ---- | -493.32%-1.02B | ---- | 21.06%-172.19M | ---- | 11.98%-218.14M | ---- | 61.29%-247.83M |
| Accounts receivable (increase)decrease | ---- | -292.14%-1.39B | ---- | 117.66%722.67M | ---- | -150.02%-4.09B | ---- | -725.33%-1.64B | ---- | -218.41%-198.32M |
| Accounts payable increase (decrease) | ---- | 189.26%927.01M | ---- | -155.96%-1.04B | ---- | 484.92%1.86B | ---- | -174.15%-482.2M | ---- | 218.24%650.31M |
| Special items for working capital changes | ---- | -233.09%-637.04M | ---- | 729.07%478.65M | ---- | 128.41%57.73M | ---- | 82.76%-203.19M | ---- | -649.25%-1.18B |
| Cash from business operations | ---- | 4.30%1.43B | ---- | 12.13%1.37B | ---- | 96.08%1.22B | ---- | -69.86%624.59M | ---- | 39.40%2.07B |
| China income tax paid | ---- | 6.19%-263.48M | ---- | 34.48%-280.88M | ---- | -8.22%-428.69M | ---- | 18.69%-396.11M | ---- | -64.52%-487.19M |
| Special items of business | 192.05%569.7M | ---- | -345.85%-618.9M | ---- | 356.14%251.74M | ---- | 94.59%-98.28M | ---- | -25.32%-1.82B | ---- |
| Net cash from operations | 192.05%569.7M | 7.00%1.17B | -345.85%-618.9M | 37.23%1.09B | 356.14%251.74M | 248.41%796.03M | 94.59%-98.28M | -85.59%228.47M | -25.32%-1.82B | 33.15%1.59B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -47.86%16.32M | -2.99%65.26M | 34.70%31.3M | 7.50%67.27M | -4.58%23.24M | 31.46%62.58M | 13.28%24.35M | -7.12%47.6M | -15.92%21.5M | 18.51%51.25M |
| Decrease in deposits (increase) | 107.49%44.5M | -2,818.17%-135.23M | -150.29%-594.25M | -97.98%4.98M | -211.60%-237.42M | 2,341.76%246.37M | 36.22%212.75M | 103.51%10.09M | 146.32%156.18M | -223.57%-287.36M |
| Sale of fixed assets | -26.57%876K | 221.05%45.12M | -43.11%1.19M | -56.12%14.05M | -87.46%2.1M | 383.10%32.03M | 15,985.58%16.73M | 116.42%6.63M | -95.54%104K | -59.55%3.06M |
| Purchase of fixed assets | 14.37%-226.19M | 7.61%-483.93M | -11.28%-264.14M | 33.45%-523.79M | 44.46%-237.37M | 30.32%-787.09M | 7.94%-427.38M | -21.70%-1.13B | 13.99%-464.23M | 3.43%-928.19M |
| Selling intangible assets | ---- | 265,250.00%10.61M | ---- | --4K | ---- | ---- | --301K | ---- | ---- | --37.4M |
| Purchase of intangible assets | 3.16%-1.32M | -34.35%-4.69M | -6.57%-1.36M | 96.13%-3.49M | -294.44%-1.28M | 26.61%-90.1M | 99.54%-324K | 49.92%-122.77M | -802.68%-70.66M | -4,797.12%-245.15M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---12K | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | --501K | --501K | ---- | ---- | 84.03%-16M | 85.99%-13.83M | -152.34%-100.17M | -4,330.43%-98.71M | 90.02%-39.7M |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -94.54%73.35M | -93.89%73.35M | -50.58%1.34B |
| Cash on investment | 93.14%-24K | -113.53%-568K | -100.00%-350K | 95.97%-266K | 93.13%-175K | 51.78%-6.59M | -4.04%-2.55M | 99.05%-13.68M | 99.82%-2.45M | 52.54%-1.43B |
| Other items in the investment business | -76.70%583K | -62.29%25.3M | -81.38%2.5M | 206.61%67.08M | 69.57%13.44M | -85.80%21.88M | -87.00%7.93M | 35.45%154.1M | 654.63%60.98M | 73.54%113.77M |
| Net cash from investment operations | 79.96%-165.25M | -27.65%-477.62M | -88.49%-824.6M | 30.32%-374.15M | -140.36%-437.49M | 50.03%-536.94M | 43.81%-182.02M | 22.38%-1.07B | 67.63%-323.93M | 10.46%-1.38B |
| Net cash before financing | 128.02%404.45M | -3.76%691.19M | -677.13%-1.44B | 177.20%718.21M | 33.73%-185.75M | 130.63%259.09M | 86.91%-280.3M | -521.38%-845.98M | 12.62%-2.14B | 156.47%200.77M |
| Cash flow from financing activities | ||||||||||
| New borrowing | 11.48%3.19B | 1.57%3.81B | -1.99%2.86B | 29.44%3.75B | 24.89%2.92B | -48.83%2.9B | 21.80%2.34B | 381.04%5.66B | 107.90%1.92B | -37.08%1.18B |
| Refund | -149.50%-2.22B | 30.16%-2.54B | 49.69%-888.41M | -18.89%-3.64B | -17.60%-1.77B | 33.26%-3.06B | -73.07%-1.5B | -125.68%-4.58B | 7.98%-867.69M | -38.06%-2.03B |
| Issuance of bonds | ---- | 0.00%3B | 10.00%2.2B | 200.00%3B | 100.00%2B | -68.75%1B | -54.55%1B | 14.29%3.2B | --2.2B | --2.8B |
| Interest paid - financing | -1.63%-108.72M | 13.53%-177.91M | 18.83%-106.98M | -0.57%-205.76M | 16.76%-131.79M | 24.20%-204.59M | -36.79%-158.33M | 13.68%-269.9M | 7.39%-115.75M | -10.43%-312.69M |
| Dividends paid - financing | 98.91%-2.61M | 17.02%-333.92M | -398.28%-240.18M | -18.73%-402.4M | -30,406.96%-48.2M | -2.63%-338.93M | 99.67%-158K | 38.65%-330.25M | 79.90%-48.53M | -6.35%-538.34M |
| Absorb investment income | ---- | ---- | ---- | -84.21%1.5M | -81.25%1.5M | -92.96%9.5M | -87.98%8M | -56.72%134.99M | -60.91%66.57M | 154.28%311.88M |
| Issuance expenses and redemption of securities expenses | 63.70%-800M | -39.96%-4.2B | -119.83%-2.2B | -198.18%-3B | 0.48%-1B | 79.05%-1.01B | 49.63%-1.01B | -92.35%-4.81B | ---2B | -100,422.72%-2.5B |
| Other items of the financing business | ---- | -189.18%-111.99M | ---- | -7,691.75%-38.73M | -5,348.39%-27.13M | ---497K | ---498K | ---- | ---- | 87.40%-16.7M |
| Net cash from financing operations | -97.07%47.07M | -4.85%-584.31M | -16.81%1.61B | 23.06%-557.28M | 189.09%1.93B | 28.60%-724.32M | -41.63%668.96M | 10.03%-1.01B | 578.85%1.15B | -163.62%-1.13B |
| Effect of rate | -76.37%95K | -60.70%373K | -46.18%402K | 134.89%949K | 1,145.00%747K | -9,814.29%-2.72M | -97.93%60K | 100.94%28K | 4,356.92%2.9M | -110.41%-2.98M |
| Net Cash | 173.19%451.52M | -33.58%106.88M | -90.55%165.28M | 134.59%160.93M | 349.79%1.75B | 74.99%-465.22M | 139.02%388.66M | -100.73%-1.86B | 62.98%-995.97M | -165.42%-926.82M |
| Begining period cash | 3.72%2.99B | 5.96%2.88B | 5.96%2.88B | -14.69%2.72B | -14.69%2.72B | -36.87%3.19B | -36.87%3.19B | -15.56%5.05B | -15.56%5.05B | 31.90%5.98B |
| Cash at the end | 12.91%3.44B | 3.72%2.99B | -31.82%3.05B | 5.96%2.88B | 24.96%4.47B | -14.69%2.72B | -11.81%3.57B | -36.87%3.19B | 23.37%4.05B | -15.56%5.05B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending HK Stocks
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK Tech and Internet Stocks, ranked from highest to lowest based on real-time market data.
